About Impladent
Impladent is a Healthcare company based in Valley Stream (United States) founded in 2002, and was acquired by SolmeteX in June 2023. Regenerative materials for bone augmentation and repair are developed. Impladent offers products and services including OsteoGen Plugs, OsteoGen Strips, CollaForm, TriStar Bone Graft Fixation System, and OsteoFlex Membrane. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is Impladent Ltd. Its competitors include Theradaptive, Aziyo Biologics and MiMedx Group; 2 of its 3 listed competitors have raised funding.
Company details
Impladent develops a range of regenerative materials including bone graft products and resorbable membranes. Products developed by the company includes OsteoGen synthetic bioactive resorbable graft for bone augmentation and repair of alveolar defects; OsteoGen non-ceramic crystals - equivalent to the human trabecular bone making this product a pure alloplast; OsteoGen bone grafting plugs - solution for socket preservation without the need for a membrane; and OsteoGen Plug combines bone graft with a bovine achilles tendon carrier to graft the extraction sites.
Products & Services of Impladent
Impladent offers a comprehensive portfolio of products and services, including OsteoGen Plugs, OsteoGen Strips, CollaForm, TriStar Bone Graft Fixation System, and OsteoFlex Membrane.
Combined graft and collagen plug for dental socket preservation.
Resorbable collagen strips for dental bone regeneration.
Absorbable collagen for tissue and graft maintenance.
Screws for secure bone graft fixation in dental procedures.
Flexible resorbable membrane for dental bone grafting support.
Investors in Impladent
Impladent has secured backing from 1 investor. Prominent investors backing the company include SolmeteX.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of water management solutions for dental practices | 1994 | solmetex.com | Norton, United States |
Investor details for Impladent
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Impladent
1 people are tracked at Impladent (1 in leadership).
| Name | Role | Group |
|---|---|---|
Maurice Valen | CEO | Leadership |
Complete people profiles for Impladent
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Impladent
2 dated milestones of Impladent across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Impladent is founded.
- Exit Acquired by SolmeteX.
Competitors of Impladent
Impladent has 3 listed competitors in our database, 2 of them funded. They include Theradaptive, Aziyo Biologics and MiMedx Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| theradaptive.com | 2004 | Boston, United States | $32.2M | 21 | Therapeutic delivery platform is developed for orthopedic clinical indications. | |
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| mimedx.com | 1985 | Marietta, United States | 735 | Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics |
Detailed competitors of Impladent
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Impladent
The website of Impladent (impladentltd.com) receives about 4.5K visits a month.
- Monthly visits4.5K
▼ 4.8% vs previous month
Websites whose visitors overlap most with Impladent. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
dess-usa.com | dess-usa.com | 100% | #582,918 | – | |
| zestdent.com | 97% | 40.4K | #600,418 | View details | |
| google.com | 51% | 85.8B | #1 | View details | |
osseonews.com | osseonews.com | 37% | #2,180,121 | – |
Top companies in Orthopedics
3 companies that operate in the same segment as Impladent (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Impladent
Complete news archive for Impladent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Impladent
Impladent was founded in 2002.
Impladent is headquartered in Valley Stream, United States. It is registered at Valley Stream, New York, United States.
Impladent develops a range of regenerative materials including bone graft products and resorbable membranes. Products developed by the company includes OsteoGen synthetic bioactive resorbable graft for bone augmentation and repair of alveolar defects; OsteoGen non-ceramic crystals - equivalent to the human trabecular bone making this product a pure alloplast; OsteoGen bone grafting plugs - solution for socket preservation without the need for a membrane; and OsteoGen Plug combines bone graft with a bovine achilles tendon carrier to graft the extraction sites.
Impladent's top competitors include Theradaptive, MiMedx Group and Aziyo Biologics.
Impladent offers OsteoGen Plugs, OsteoGen Strips, CollaForm, TriStar Bone Graft Fixation System, and OsteoFlex Membrane.
Impladent has 1 investor. Key investors include SolmeteX.
Impladent operates through Impladent Ltd.
Yes. Impladent was acquired by SolmeteX in June 2023.